Зрелый возраст - Эммонс Генри - Страница 66

87. B. Luscombe, “Your Brain Cells Shrink While You Sleep (And That’s a Good Thing)," Time, Oct. 17, 2013, accessed Feb. 23,2014, http://healthland.time. com/2013/10/17/your-brain-cells-shrink-while-you-sleep-and-thats-a-good-thing/#ixzz2uBRM9BAD.

6. Мозгу нужно хорошее питание: шаг третий

88. Q. Yang et al., “Added Sugar Intake and Cardiovascular Diseases Mortality among US Adults,” JAMA Internal Medicine 2014, doi:10.1001/jamain ternmed.2013.13563.

89. R. Chowdhury et al., “Association of Dietary, Circulating, and Supplement Fatty Acids with Coronary Risk: A Systematic Review and Meta-analysis,” Archives of Internal Medicine 160, no. 6 (Mar. 2014): 398-406.

90. http://well.blogs.nytimes.com/2014/03/17/study-questions-fat-and-heart-disease-link/?php=true&type=blogs&r=0.

91. www.gallup.com/poll/165671/obesity-rate-climbing-2013.aspx.

92. K. Duffy and B. Popkin, “Energy Density, Portion Size, and Eating Occasions: Contributions to Increased Energy Intake in the United States, 1977-2006,” PLoS Medicine, 2011, doi:10.1371 journal.pmedl001050.

93. G. Vistoli et al., “Advanced Glycoxidation and Lipoxidation End Products (AGEs and ALEs): An Overview of Their Mechanisms of Formation,” Free Radical Research 47, no. 12 (Aug. 2013): Supplement 1:3-27.

94. S. Shaikh et al., “Advanced Glycation End Products Induce in Vitro Cross-Linking of Alpha-Synudein and Accelerate the Process of Intracellular Inclusion Body Formation,” Journal of Neuroscience Research 86, no. 9 (July 2008): 2071-82.

95. C. Carvalho et al., “Increased Susceptibility to Amyloid-b Toxicity in Rat Brain Microvascular Endothelial Cells under Hyperglycemic Conditions,” Journal of Alzheimer’s Disease 38, no. 1 (Oct. 2013): 75-83.

96. N. Cherbuin et al., “Higher Normal Fasting Plasma Glucose Is Associated with Hippocampal Atrophy: The PATH Study,” Neurology 79, no. 10 (Sept. 4,2012): 1019-26.

97. P. Crane et al., “Glucose Levels and Risk of Dementia,” New England Journal of Medicine 369 (Aug. 8,2013): 540-48.

98. R. Wilson et al., “Proneness to Psychological Distress Is Associated with Risk of Alzheimer’s Disease,” Neurology 61 (2003):1479-85.

99. L. Tsai and R. Madabhushi, “Alzheimer’s disease: A Protective Factor for the Ageing Brain," Nature 507 (Mar. 27,2014): 439-40, doi:10.1038/naturel3214.

100. M. Parrott and C. Greenwood, “Dietary Influences on Cognitive Function with Aging: From High-Fat Diets to Healthful Eating,” Annals of the New York Academy of Sciences 1114 (2007): 389-97.

101. A. Rubio-Tapia et al., “Increased Prevalence and Mortality in Undiagnosed Celiac Disease,” Gastroenterology 137, no. 1 (July 2009): 88-93, doi:10.1053/j. gastro.2009.03.059.

102. A. Vajdani, “The Characterization of the Repertoire of Wheat Antigens and Peptides Involved in the Humoral Immune Responses in Patients with Gluten Sensitivity and Crohn’s Disease,” ISRN Allergy (Oct. 27, 2011), doi:10.5402/2011/950104.

103. S. Collins et al., “The Adoptive Transfer of Behavioral Phenotype via the Intestinal Microbiota: Experimental Evidence and Clinical Implications,” Current Opinion in Microbiology 16, no. 3 (June 2013): 240-45.

104. G. Clarke et al., “The Microbiome-Gut-Brain Axis during Early Life Regulates the Hippocampal Serotonergic System in a Sex-Dependent Manner.” Molecular Psychiatry 18. no. 6 (June 12. 2012): 666-73, doi:10.1038/mp.2012.77.

105. T. Dinan et al., “Psychobiotics: A Novel Class of Psychotropic,” Biological Psychiatry 74, no. 10 (Nov. 15,2013): 720-26.

106. J. Bravo et al., “Ingestion of Lactobacillus Strain Regulates Emotional Behavior and Central GABA Receptor Expression in a Mouse via The Vagus Nerve,” Proceedings of the National Academy of Sciences 108, no. 38 (2011): 16050-55, doi:10.1073/pnas.l02999108.

107. J. Markle et al., "Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity,” Science 339, no. 6123 0an. 17,2013): 1084-88, doi:10.1126/science.l233521.

108. Helmholtz Centre For Environmental Research — UFZ, “GI Tract Bacteria May Protect against Autoimmune Disease,” ScienceDaily, Jan. 17,2013.

109. M. Houston, “The Role of Nutrition and Nutraceutical Supplements in the Treatment of Hypertension,” WorldJournal of Cardiology 6, no. 2 (Feb. 26,2014): 38-66.

110. T. Pentinat et al., “Transgenerational Inheritance of Glucose Intolerance in a Mouse Model of Neonatal Overnutrition," Endocrinology 151, no. 12 (Dec. 2010): 5617-23, doi:10.1210/en.2010-0684.

111. G. Kaati et al. “Cardiovascular and Diabetes Mortality Determined by Nutrition during Parents’ and Grandparents’ Slow Growth Period,” European Journal of Human Genetics 10 (2002): 682-88.

112. H. Tapp et al., “Nutritional Factors and Gender Influence Age-Related DNA Methylation In the Human Rectal Mucosa,” Aging Cell (2012), doi:10.1111/ acel.12030.

113. J.V. Sanchez-Mut et al., “Promoter Hypermethylation of the Phosphatase DUSP22 Mediates РКА-Dependent TAU Phosphorylation and CREB Activation in Alzheimer’s Disease,” Hippocampus (2014), doi:10.1002/hipo.22245.

114. P. Elwood et al., “Healthy Lifestyles Reduce the Incidence of Chronic Diseases and Dementia: Evidence from the Caerphilly Cohort Study,” PLoS One (Dec. 2013), doi:10.1371/journal.pone.0081877.

115. D. Ornish et al., “Effect of Comprehensive Lifestyle Changes on Telomerase Activity and Telomere Length in Men with Biopsy-Proven Low-Risk Prostate Cancer: 5-Year Follow-Up of a Descriptive Pilot Study,” Lancet Oncology 14, no. 11 (Oct. 2013): 1112-20.

116. A. Tiainen et al., “Leukocyte Telomere Length and Its Relation to Food and Nutrient Intake in an Elderly Population,” European Journal of Clinical Nutrition, 66, no. 12 (Dec. 2012): 1290-94.

117. http://epic.iarc.fr/keyfindings.php.

118. E. Guallar et al., “Enough Is Enough: Stop Wasting Money on Vitamin and Mineral Supplements,” Annals of Internal Medicine 159, no. 12 (Dec. 17,2013): 850-51.

119. F. Grodstein et al., “A Randomized Trial of Long-term Multivitamin Supplementation and Cognitive Function in Men: The Physicians’ Health Study II," Annals of Internal Medicine 159, no. 12 (Dec. 17,2013): 806-14.

120. J. Walker et al., “Oral Folic Acid and Vitamin B-12 Supplementation to Prevent Cognitive Decline in Community-Dwelling Older Adults with Depressive Symptoms — The Beyond Ageing Project: A Randomized Controlled Trial, American Journal of Clinical Nutrition 95, no. 1 0an. 2012): 194-203.

121. A.D. Smith et al., “Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial,” PLoS One 5, no. 9 (Sept. 2010), doi:10.1371/journal. pone.0012244.

122. B. Small et al., “Nutraceutical Intervention Improves Older Adults’ Cognitive Functioning.” Rejuvenation Research, 17, no. 1 (Feb. 2014): 27-32.

123. G. Douaud et al., “Preventing Alzheimer’s Disease-Related Gray Matter Atrophy by B-Vitamin Treatment,” Proceedings of the National Academy of Sciences 110, no. 23 (June 2013): 9523-28.

124. http://www.sciencedaily.com/releases/2013/ll/131104142343.htm.

125. J. Dysken et al., “Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Diseas e" JAMA 311, no. 1 (Jan. 2014): 33-44.

126. J. Sanmukhani et al.. “Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial,” Phytotherapy Research 28, no. 4 (Apr. 2014): 579-85.

127. T. Crook et al., “Effects of Phosphatidylserine in Alzheimer’s disease,” Pharmacology Bulletin 28, no. 1 (1992): 61-66.